Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Joanna C Huang"'
Autor:
Joanna C. Huang, Sonu M. M. Bhaskar
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 20, p 12373 (2022)
Stroke is a leading cause of death and disability in the world, and the provision of reperfusion therapy and endovascular therapy, in particular, have revolutionized the treatment of patients with stroke and opened opportunities to look at brain clot
Externí odkaz:
https://doaj.org/article/e64b24a99b684d5e8b62c75688d11df2
Autor:
Jacob B. Pierce, Muthiah Vaduganathan, Gregg C. Fonarow, Uchechukwu Ikeaba, Karen Chiswell, Javed Butler, Adam D. DeVore, Paul A. Heidenreich, Joanna C. Huang, Michelle M. Kittleson, Karen E. Joynt Maddox, Karthik K. Linganathan, James J. McDermott, Anjali Tiku Owens, Pamela N. Peterson, Scott D. Solomon, Orly Vardeny, Clyde W. Yancy, Stephen J. Greene
Publikováno v:
JAMA Cardiology.
ImportanceClinical guidelines for patients with heart failure with reduced ejection fraction (HFrEF) strongly recommend treatment with a sodium-glucose cotransporter-2 inhibitor (SGLT2i) to reduce cardiovascular mortality or HF hospitalization. Natio
Autor:
Adam D. DeVore, Nicole Solomon, Paul A. Heidenreich, Anjali T. Owens, Muthiah Vaduganathan, James J McDermott, Clyde W. Yancy, Shuaiqi Zhang, Pamela N. Peterson, Michelle M. Kittleson, Stephen J. Greene, Orly Vardeny, Karen E. Joynt Maddox, Gregg C. Fonarow, Javed Butler, Scott D. Solomon, Karen Chiswell, Joanna C. Huang
Publikováno v:
Journal of cardiac failure. 28(4)
The sodium-glucose cotransporter-2 (SGLT-2) inhibitors form the latest pillar in the management of heart failure with reduced ejection fraction (HFrEF) and appear to be effective across a range of patient profiles. There is increasing interest in ini
Autor:
Brooke Alhanti, Stephen J. Greene, James J McDermott, Karen E. Joynt Maddox, Paul A. Heidenreich, Pamela N. Peterson, Shuaiqi Zhang, Muthiah Vaduganathan, Gregg C. Fonarow, Michelle M. Kittleson, Javed Butler, Anjali T. Owens, Scott D. Solomon, Adam D. DeVore, Clyde W. Yancy, Orly Vardeny, Ravi B. Patel, Joanna C. Huang
Publikováno v:
Journal of the American College of Cardiology. 78(4)
Background Few contemporary data exist evaluating care patterns and outcomes in heart failure (HF) across the spectrum of kidney function. Objectives This study sought to characterize differences in quality of care and outcomes in patients hospitaliz
Autor:
Anjali T. Owens, Muthiah Vaduganathan, Javed Butler, Joanna C. Huang, Michelle M. Kittleson, Jim McDermott, Stephen J. Greene, Clyde W. Yancy, Paul A. Heidenreich, Gregg C. Fonarow, Orly Vardeny, Karen E. Joynt Maddox, Shuaiqi Zhang, Pamela N. Peterson, Adam D. DeVore, Maria V. Grau-Sepulveda, Scott D. Solomon
Publikováno v:
Circulation. 142
Background: In May 2020, dapagliflozin was approved by the US FDA as the first SGLT-2 inhibitor for HF with reduced ejection fraction (HFrEF) based on the pivotal DAPA-HF trial. Limited data are available characterizing its generalizability to US cli
Autor:
Pamela N. Peterson, Michelle M. Kittleson, Javed Butler, Scott D. Solomon, Muthiah Vaduganathan, Paul A. Heidenreich, Clyde W. Yancy, Stephen J. Greene, Shuaiqi Zhang, Maria V. Grau-Sepulveda, Orly Vardeny, Gregg C. Fonarow, Anjali T. Owens, Karen E. Joynt Maddox, Joanna C. Huang, James J McDermott, Adam D. DeVore
Publikováno v:
JAMA Cardiol
IMPORTANCE: In May 2020, dapagliflozin was approved by the US Food and Drug Administration (FDA) as the first sodium-glucose cotransporter 2 inhibitor for heart failure with reduced ejection fraction (HFrEF), based on the Dapagliflozin and Prevention
To derive current real-world data on the rates and costs of severe hypoglycemia (SH) for people with type 2 diabetes mellitus (T2D) who have initiated basal insulin therapy and to examine differences in SH rates and costs stratified by history of pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f553fc05238e84786f668b1bdc89222e
Publikováno v:
Pharmacoepidemiology and Drug Safety. 26:368-377
Purpose We compared methods to control bias and confounding in observational studies including inverse probability weighting (IPW) and stabilized IPW (sIPW). These methods often require iteration and post-calibration to achieve covariate balance. In
Publikováno v:
Current Medical Research and Opinion. 31:1809-1815
Past studies have found episodes of severe hypoglycemia (SH) to be serially dependent. Those studies, however, only considered the impact of a single (index) event on future risk; few have analyzed SH risk as it evolves over time in the presence (or
Publikováno v:
Pharmacoeconomics
Background Electronic medical records and insurance claims data from the Geisinger Health System were examined to assess the real-world healthcare costs of being overweight or obese at different glycemic stages, including normal glycemia, pre-diabete